Integral Diagnostics upgraded by RBC Capital: "We have upgraded IDX to Outperform as we believe the stock has a positive near-term outlook and offers an appealing risk/reward profile. "Our PT has increased to $3.15/share (from $2.30/share) due to earnings revisions and a roll forward of our DCF valuation."
- Forums
- ASX - By Stock
- 4DX
- News: 4DX 4Dmedical Ltd Says Entered Contract With Integral Diagnostics
News: 4DX 4Dmedical Ltd Says Entered Contract With Integral Diagnostics, page-7
Featured News
Add 4DX (ASX) to my watchlist
|
|||||
Last
53.5¢ |
Change
0.015(2.88%) |
Mkt cap ! $219.6M |
Open | High | Low | Value | Volume |
52.3¢ | 54.0¢ | 52.0¢ | $155.5K | 291.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9297 | 53.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.5¢ | 25000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9297 | 0.535 |
4 | 60161 | 0.525 |
5 | 20873 | 0.520 |
7 | 83654 | 0.515 |
14 | 121582 | 0.510 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 25000 | 2 |
0.550 | 14617 | 2 |
0.555 | 5000 | 1 |
0.560 | 40000 | 1 |
0.565 | 5002 | 1 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online